JPS5069072A - - Google Patents

Info

Publication number
JPS5069072A
JPS5069072A JP49082669A JP8266974A JPS5069072A JP S5069072 A JPS5069072 A JP S5069072A JP 49082669 A JP49082669 A JP 49082669A JP 8266974 A JP8266974 A JP 8266974A JP S5069072 A JPS5069072 A JP S5069072A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49082669A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2337154A external-priority patent/DE2337154C2/en
Priority claimed from DE2431292A external-priority patent/DE2431292A1/en
Application filed filed Critical
Publication of JPS5069072A publication Critical patent/JPS5069072A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP49082669A 1973-07-18 1974-07-18 Pending JPS5069072A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2337154A DE2337154C2 (en) 1973-07-18 1973-07-18 New carbazole derivatives
DE2431292A DE2431292A1 (en) 1974-06-27 1974-06-27 Anti-inflammatory carbazole derivs - specif. e.g. 1-ethoxycarbonyl-6-methoxy-carbazole and 8-methyl-carbazole-1-carboxylic acid

Publications (1)

Publication Number Publication Date
JPS5069072A true JPS5069072A (en) 1975-06-09

Family

ID=25765532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49082669A Pending JPS5069072A (en) 1973-07-18 1974-07-18

Country Status (20)

Country Link
JP (1) JPS5069072A (en)
AT (1) AT342583B (en)
BG (1) BG25793A3 (en)
CA (1) CA1053682A (en)
CH (1) CH619213A5 (en)
CS (1) CS190431B2 (en)
DD (1) DD114075A5 (en)
DK (1) DK388074A (en)
ES (1) ES428379A1 (en)
FI (1) FI218874A7 (en)
FR (1) FR2237628B1 (en)
GB (1) GB1482771A (en)
HU (1) HU173115B (en)
IE (1) IE39624B1 (en)
IL (1) IL45298A (en)
NL (1) NL7409715A (en)
NO (1) NO742601L (en)
RO (1) RO72713A (en)
SE (1) SE396602B (en)
SU (1) SU511855A3 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505148A (en) * 2003-09-12 2007-03-08 エリクサー ファーマスーティカルズ インコーポレイテッド Treatment of disease
JP2008513370A (en) * 2004-09-13 2008-05-01 エリクシアー ファーマシューティカルズ, インコーポレイテッド How to treat the failure
JP2008520741A (en) * 2004-11-23 2008-06-19 ピーティーシー セラピューティクス, インコーポレイテッド Tetrahydrocarbazole as an activator to inhibit translation-controlled VEGF production
JP2014530839A (en) * 2011-10-20 2014-11-20 シエナ バイオテク エス.ピー.エー. Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and its precursor
JP2020516664A (en) * 2017-04-11 2020-06-11 セージ ファーマ, エルエルシー Carbazole compound and method of using the same
JP2021134141A (en) * 2020-02-21 2021-09-13 エヌ・イーケムキャット株式会社 Method for producing aromatic compound using heterogeneous noble metal catalyst

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005518375A (en) * 2001-12-14 2005-06-23 ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング Tetrahydrocarbazole derivatives as ligands for G protein coupled receptors (GPCRs)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7008628A (en) * 1969-06-25 1970-12-29

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505148A (en) * 2003-09-12 2007-03-08 エリクサー ファーマスーティカルズ インコーポレイテッド Treatment of disease
JP2008513370A (en) * 2004-09-13 2008-05-01 エリクシアー ファーマシューティカルズ, インコーポレイテッド How to treat the failure
JP2008520741A (en) * 2004-11-23 2008-06-19 ピーティーシー セラピューティクス, インコーポレイテッド Tetrahydrocarbazole as an activator to inhibit translation-controlled VEGF production
US8946444B2 (en) 2004-11-23 2015-02-03 Ptc Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
JP2014530839A (en) * 2011-10-20 2014-11-20 シエナ バイオテク エス.ピー.エー. Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and its precursor
US10329254B2 (en) 2011-10-20 2019-06-25 Aop Orphan Pharmaceuticals Ag Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and intermediates thereof
JP2020516664A (en) * 2017-04-11 2020-06-11 セージ ファーマ, エルエルシー Carbazole compound and method of using the same
JP2021134141A (en) * 2020-02-21 2021-09-13 エヌ・イーケムキャット株式会社 Method for producing aromatic compound using heterogeneous noble metal catalyst

Also Published As

Publication number Publication date
HU173115B (en) 1979-02-28
FR2237628A1 (en) 1975-02-14
IE39624B1 (en) 1978-11-22
IL45298A0 (en) 1974-10-22
DK388074A (en) 1975-03-03
FR2237628B1 (en) 1977-05-20
BG25793A3 (en) 1978-12-12
RO72713A (en) 1982-09-09
CH619213A5 (en) 1980-09-15
SE396602B (en) 1977-09-26
IL45298A (en) 1980-01-31
SU511855A3 (en) 1976-04-25
IE39624L (en) 1975-01-18
GB1482771A (en) 1977-08-17
DD114075A5 (en) 1975-07-12
FI218874A7 (en) 1975-01-19
AT342583B (en) 1978-04-10
ES428379A1 (en) 1976-09-16
SE7409330L (en) 1975-01-20
ATA596074A (en) 1977-08-15
CA1053682A (en) 1979-05-01
NL7409715A (en) 1975-01-21
CS190431B2 (en) 1979-05-31
NO742601L (en) 1975-02-17

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AU476761B2 (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU465434B2 (en)
AU450229B2 (en)
AU476714B2 (en)
FR2237628B1 (en)
AR201229Q (en)
AU472848B2 (en)
AR199451A1 (en)
AU466283B2 (en)
AU476696B2 (en)
AU477823B2 (en)
AR201432A1 (en)
AR200256A1 (en)
AU461342B2 (en)
AU447540B2 (en)
AU476873B1 (en)
AU477824B2 (en)
AR210729A1 (en)